Cargando…

Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond

SIMPLE SUMMARY: The recent emergence of targeted therapies, including antibody–drug conjugates, bispecific antibodies, and CD19 chimeric antigen receptor (CAR) T cell therapy, revolutionized B-lineage acute lymphoblastic leukemia (B-ALL) management, allowing certain optimism, at least for adult pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aureli, Anna, Marziani, Beatrice, Venditti, Adriano, Sconocchia, Tommaso, Sconocchia, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340788/ https://www.ncbi.nlm.nih.gov/pubmed/37444456 http://dx.doi.org/10.3390/cancers15133346

Ejemplares similares

Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia
por: Aureli, Anna, et al.
Publicado: (2021)

Regulation of the Immune System in Health and Disease by Members of the Bone Morphogenetic Protein Family
por: Sconocchia, Tommaso, et al.
Publicado: (2021)

Langerhans cell histiocytosis: current advances in molecular pathogenesis
por: Sconocchia, Tommaso, et al.
Publicado: (2023)

Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage
por: Arriga, Roberto, et al.
Publicado: (2015)

Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia: Diagnostic Tools, Prophylaxis, and Therapy
por: Del Principe, Maria Ilaria, et al.
Publicado: (2014)

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
por: Caratelli, Sara, et al.
Publicado: (2017)

Pulmonary function testing for fitness assessment in asymptomatic adults with newly diagnosed acute myeloid leukemia
por: Palmieri, Raffaele, et al.
Publicado: (2022)

Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment
por: Sconocchia, Giuseppe, et al.
Publicado: (2022)

Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage
por: Canossi, Angelica, et al.
Publicado: (2016)

Asparagine Synthetase in Cancer: Beyond Acute Lymphoblastic Leukemia
por: Chiu, Martina, et al.
Publicado: (2020)

Next-Generation Sequencing in Acute Lymphoblastic Leukemia
por: Coccaro, Nicoletta, et al.
Publicado: (2019)

Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
por: Śliwa-Tytko, Patrycja, et al.
Publicado: (2022)

Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell–Redirected Bispecific Antibodies
por: Lussana, Federico, et al.
Publicado: (2021)

Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia
por: Bayón-Calderón, Fátima, et al.
Publicado: (2020)

Supportive methods for childhood acute lymphoblastic leukemia then and now: A compilation for clinical practice
por: Podpeskar, Alexandra, et al.
Publicado: (2022)

NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma
por: Coppola, Andrea, et al.
Publicado: (2015)

Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomab
por: Litzow, Mark R
Publicado: (2014)

The Role of ARID5B in Acute Lymphoblastic Leukemia and Beyond
por: Wang, Peiqi, et al.
Publicado: (2020)

Next‐generation sequencing for BCR‐ABL1 kinase domain mutations in adult patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A position paper
por: Soverini, Simona, et al.
Publicado: (2020)

Highlights on the Role of Galectin-3 in Colorectal Cancer and the Preventive/Therapeutic Potential of Food-Derived Inhibitors
por: Aureli, Anna, et al.
Publicado: (2022)

Targeted Treatment and Immunotherapy in High-risk and Relapsed/Refractory Pediatric Acute Lymphoblastic Leukemia
por: Graiqevci-Uka, Violeta, et al.
Publicado: (2022)

The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives
por: Caracciolo, Daniele, et al.
Publicado: (2023)

Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
por: Wei, Guoqing, et al.
Publicado: (2017)

Management of toxicities associated with novel immunotherapy agents in acute lymphoblastic leukemia
por: Jain, Tania, et al.
Publicado: (2020)

Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
por: Lv, Meng, et al.
Publicado: (2022)

Improving accuracy of corneal power measurement with partial coherence interferometry after corneal refractive surgery using a multivariate polynomial approach
por: Lanza, Michele, et al.
Publicado: (2018)

Immunotherapy and Allogeneic Bone Marrow Transplantation in B Acute Lymphoblastic Leukemia: How to Sequence?
por: Komitopoulou, Anna, et al.
Publicado: (2022)

Improving the Treatment of Acute Lymphoblastic Leukemia
por: Radadiya, Ashish, et al.
Publicado: (2020)

Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma
por: Pasqualone, Gianmario, et al.
Publicado: (2022)

Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications
por: Del Principe, Maria Ilaria, et al.
Publicado: (2016)

Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
por: Zhang, Ziting, et al.
Publicado: (2022)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
por: Schnorfeil, Frauke, et al.
Publicado: (2014)

Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies
por: Munir, Faryal, et al.
Publicado: (2023)

Application of targeted next generation sequencing for the mutational profiling of patients with acute lymphoblastic leukemia
por: Janic, Dragana, et al.
Publicado: (2020)

Evaluation of Donor and Recipient Characteristics Involved in Descemet Stripping Automated Endothelial Keratoplasty Outcomes
por: Lanza, Michele, et al.
Publicado: (2021)

Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
por: Savoy, J. Michael, et al.
Publicado: (2018)

Harnessing the Immune System: Current and Emerging Immunotherapy Strategies for Pediatric Acute Lymphoblastic Leukemia
por: Glasser, Chana L., et al.
Publicado: (2023)

Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
por: Cooper, Todd M
Publicado: (2007)

P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy
por: Sconocchia, G, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3opmqhirooi8f8266ovougiv4r